University Professor of Epidemiology and Medicine at Columbia University / HIV Prevention Trials Network
Wafaa El-Sadr, MD, MPH, MPA is a University Professor of Epidemiology and Medicine at Columbia University, the director of ICAP at Columbia University, and director of the Global Health Initiative at the Mailman School of Public Health.
Founded by Dr. El-Sadr, ICAP is a global leader in HIV, other global health threats, and health systems strengthening that provides technical assistance, implementation support, and conducts research in partnership with governmental and non-governmental organizations in more than 21 countries. In this role, she leads the design, implementation, scale-up, and evaluation of large-scale HIV, tuberculosis (TB) and maternal-child health programs in sub-Saharan Africa and Asia that provide access to HIV services to more than 2.2 million people and collect data from more than 5,200 health facilities.
Dr. El-Sadr is a prominent researcher and has led numerous epidemiological, clinical, behavioral, and implementation science research studies that have furthered the understanding of the prevention and management of HIV, TB, and non-communicable diseases. She is a principal investigator of the NIH-funded HIV Prevention Trials Network (HPTN), which seeks to prevent HIV transmission, globally.
Dr. El-Sadr is a member of the NIH Fogarty International Center Advisory Board. In 2008, she was named a John D. and Catherine T. MacArthur Foundation Fellow, and in 2009, she was appointed to the National Academy of Medicine. In 2013, she was appointed University Professor, Columbia’s highest academic honor. She also holds the Dr. Mathilde Krim-amfAR Chair in Global Health.